Margetuximab Antibody

SKU: orb1980753

Description

Margetuximab (MGAH-22) is a second-generation, Fc-engineered monoclonal antibody targeting HER2, used in research for metastatic HER2-positive breast cancer. It is applied in both in vitro cell studies and in vivo tumor models to investigate therapeutic mechanisms and serves as a component in the development of targeted nanomedicines.

Research Area

Cardiovascular Research, Signal Transduction

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Monoclonal
Target	HER,EGFR
Molecular Weight	145.86 kDa
Purity	95.00% (May vary between batches)
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Concentration	14.34 mg/mL
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

MGAH22, MGAH-22

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

HER,EGFR

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols